Aspirin PDF
Aspirin PDF
In order to clearly identify the material for the two separate problems, each problem
is presented in its entirety within a labeled frame. Since there are similarities between the
two problems, some of the same information appears in both problem descriptions.
Project Description
In the manufacture of aspirin, acetylsalicylic acid (ASA, the active ingredient in aspirin) is synthesized using the reaction
The presence of phosphoric acid catalyzes the irreversible reaction, which proceeds with kinetics that are first-order with respect
to salicylic acid concentration (kreaction = 0.5 s−1 ). Further, the reaction is exothermic (∆Hreact = −85, 800 J/gmol of salicylic acid
reacted). A simplified process is described below:
The following three streams will be continuously fed to a reactor at 70◦C:
The salicylic acid will enter the reactor as a crystalline solid but will dissolve in the acetic anhydride.
The reactor is a continuously stirred tank reactor, where 99.5% of the salicylic acid will be converted to acetylsalicylic acid
(also dissolved). Furthermore, the contents of the reactor will be maintained at 70◦C in the reactor by a cooling jacket around the
reactor (carrying cooling water as needed).
The outlet stream from the reactor will flow to a mixer where it will be joined by an additional stream of ultrapure water (22,000
L/hr, 25◦C). The water will react with the excess acetic anhydride to form more acetic acid, according to the reaction
This reaction proceeds to 100% conversion in the mixer, so the sizing of a “reactor” for this step is not necessary. Further, this
reaction is also exothermic, but the extent of this reaction is small enough in this case to justify neglecting the heat of the reaction.
The mixed product stream leaving the mixer will enter a centrifugal pump, which will boost the pressure to the value needed to
pass through the remainder of the process (leaving the final filtration sequence at atmospheric pressure).
The stream leaving the pump will enter a product cooler (a heat exchanger) in which it will be cooled to 25◦C using cooling
water as the other stream in the exchanger.
The water addition and cooling step will promote the crystallization of the acetylsalicylic acid (and any unreacted salicylic
acid), and the stream will then enter a filtration sequence to separate the crystals (aspirin stream) from the other byproducts (acetic
acid byproduct stream, which is sold).
Technical Details
1. Individual Properties
2. Treat the concentrated phosphoric acid (95% PA, 5% water) as pure phosphoric acid.
3. Assume the following stream heat capacities:
9. The separation system uses a complex scheme of multiple steps. For this preliminary design, simply represent the separation
system by a box labeled “Separation System.”
10. The cost of the separation system can be approximated as $2.9 million (delivered price).
11. The following market costs/values apply:
13. The total operating cost per year can be estimated as 1.55 times the sum of the feed cost, cooling water costs, and electricity
costs (excluding the filtration sequence, for which these values are not known). In other words,
14. The direct capital costs for the reactor, heat exchangers, and pump can be estimated from the formulas in Table 13.2 and
using the current value of the M&S Index (look in the back of a current issue of the magazine Chemical Engineering2 ).
15. The current tax rate is 35%; we are allowed to depreciate our equipment over 10 years; and our company requires a minimum
ROI of 0.15. In our case, 85% of the capital investment can be depreciated.
220 Chapter 14 Case Studies
Assignment